View in EDS

Phase III KEYNOTE-789 Study of Pemetrexed and Platinum With or Without Pembrolizumab for Tyrosine Kinase Inhibitor‒Resistant, EGFR-Mutant, Metastatic Nonsquamous Non-Small Cell Lung Cancer.

Saved in:
Bibliographic Details
Title: Phase III KEYNOTE-789 Study of Pemetrexed and Platinum With or Without Pembrolizumab for Tyrosine Kinase Inhibitor‒Resistant, EGFR-Mutant, Metastatic Nonsquamous Non-Small Cell Lung Cancer.
Authors: Yang JC; National Taiwan University Hospital and National Taiwan University Cancer Center, Taipei, Taiwan., Lee DH; Department of Oncology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea., Lee JS; Seoul National University Bundang Hospital, Seoul, South Korea., Fan Y; Zhejiang Cancer Hospital, Hangzhou, China., de Marinis F; Istituto Europeo di Oncologia, IRCCS, Milan, Italy., Iwama E; Department of Respiratory Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan., Inoue T; Osaka International Cancer Institute, Osaka, Japan., Rodríguez-Cid J; Oncology Center, Medica Sur Hospital, Mexico City, Mexico., Zhang L; Peking Union Medical College Hospital, Beijing, China., Yang CT; Chang Gung Memorial Hospital, Taoyuan, Taiwan., de la Mora Jimenez E; Instituto Jalisciense de Cancerología, Guadalajara, Mexico., Zhou J; The First Affiliated Hospital, Zhejiang University, Zhejiang, China., Pérol M; Centre Léon Bérard, Lyon, France., Lee KH; Chungbuk National University Hospital, Cheongju-si, South Korea., Vicente D; Hospital Universitario Virgen Macarena, Sevilla, Spain., Ichihara E; Okayama University Hospital, Okayama, Japan., Riely GJ; Memorial Sloan Kettering Cancer Center, New York, NY., Luo Y; Merck & Co, Inc, Rahway, NJ., Chirovsky D; Merck & Co, Inc, Rahway, NJ., Pietanza MC; Merck & Co, Inc, Rahway, NJ., Bhagwati N; Merck & Co, Inc, Rahway, NJ., Lu S; Shanghai Chest Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, China.
Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Dec; Vol. 42 (34), pp. 4029-4039. Date of Electronic Publication: 2024 Aug 22.
Publication Type: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial; Multicenter Study; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39173098
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Phase III KEYNOTE-789 Study of Pemetrexed and Platinum With or Without Pembrolizumab for Tyrosine Kinase Inhibitor‒Resistant, EGFR-Mutant, Metastatic Nonsquamous Non-Small Cell Lung Cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Yang+JC%22">Yang JC</searchLink>; National Taiwan University Hospital and National Taiwan University Cancer Center, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Lee+DH%22">Lee DH</searchLink>; Department of Oncology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea.<br /><searchLink fieldCode="AU" term="%22Lee+JS%22">Lee JS</searchLink>; Seoul National University Bundang Hospital, Seoul, South Korea.<br /><searchLink fieldCode="AU" term="%22Fan+Y%22">Fan Y</searchLink>; Zhejiang Cancer Hospital, Hangzhou, China.<br /><searchLink fieldCode="AU" term="%22de+Marinis+F%22">de Marinis F</searchLink>; Istituto Europeo di Oncologia, IRCCS, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Iwama+E%22">Iwama E</searchLink>; Department of Respiratory Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.<br /><searchLink fieldCode="AU" term="%22Inoue+T%22">Inoue T</searchLink>; Osaka International Cancer Institute, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Rodríguez-Cid+J%22">Rodríguez-Cid J</searchLink>; Oncology Center, Medica Sur Hospital, Mexico City, Mexico.<br /><searchLink fieldCode="AU" term="%22Zhang+L%22">Zhang L</searchLink>; Peking Union Medical College Hospital, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Yang+CT%22">Yang CT</searchLink>; Chang Gung Memorial Hospital, Taoyuan, Taiwan.<br /><searchLink fieldCode="AU" term="%22de+la+Mora+Jimenez+E%22">de la Mora Jimenez E</searchLink>; Instituto Jalisciense de Cancerología, Guadalajara, Mexico.<br /><searchLink fieldCode="AU" term="%22Zhou+J%22">Zhou J</searchLink>; The First Affiliated Hospital, Zhejiang University, Zhejiang, China.<br /><searchLink fieldCode="AU" term="%22Pérol+M%22">Pérol M</searchLink>; Centre Léon Bérard, Lyon, France.<br /><searchLink fieldCode="AU" term="%22Lee+KH%22">Lee KH</searchLink>; Chungbuk National University Hospital, Cheongju-si, South Korea.<br /><searchLink fieldCode="AU" term="%22Vicente+D%22">Vicente D</searchLink>; Hospital Universitario Virgen Macarena, Sevilla, Spain.<br /><searchLink fieldCode="AU" term="%22Ichihara+E%22">Ichihara E</searchLink>; Okayama University Hospital, Okayama, Japan.<br /><searchLink fieldCode="AU" term="%22Riely+GJ%22">Riely GJ</searchLink>; Memorial Sloan Kettering Cancer Center, New York, NY.<br /><searchLink fieldCode="AU" term="%22Luo+Y%22">Luo Y</searchLink>; Merck & Co, Inc, Rahway, NJ.<br /><searchLink fieldCode="AU" term="%22Chirovsky+D%22">Chirovsky D</searchLink>; Merck & Co, Inc, Rahway, NJ.<br /><searchLink fieldCode="AU" term="%22Pietanza+MC%22">Pietanza MC</searchLink>; Merck & Co, Inc, Rahway, NJ.<br /><searchLink fieldCode="AU" term="%22Bhagwati+N%22">Bhagwati N</searchLink>; Merck & Co, Inc, Rahway, NJ.<br /><searchLink fieldCode="AU" term="%22Lu+S%22">Lu S</searchLink>; Shanghai Chest Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, China.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228309333%22">Journal of clinical oncology : official journal of the American Society of Clinical Oncology</searchLink> [J Clin Oncol] 2024 Dec; Vol. 42 (34), pp. 4029-4039. <i>Date of Electronic Publication: </i>2024 Aug 22.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial; Multicenter Study; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Clinical+Oncology%22">American Society of Clinical Oncology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8309333 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1527-7755 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220732183X%22">0732183X </searchLink><i>NLM ISO Abbreviation: </i>J Clin Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39173098
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1200/JCO.23.02747
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 4029
    Titles:
      – TitleFull: Phase III KEYNOTE-789 Study of Pemetrexed and Platinum With or Without Pembrolizumab for Tyrosine Kinase Inhibitor‒Resistant, EGFR-Mutant, Metastatic Nonsquamous Non-Small Cell Lung Cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Yang JC
      – PersonEntity:
          Name:
            NameFull: Lee DH
      – PersonEntity:
          Name:
            NameFull: Lee JS
      – PersonEntity:
          Name:
            NameFull: Fan Y
      – PersonEntity:
          Name:
            NameFull: de Marinis F
      – PersonEntity:
          Name:
            NameFull: Iwama E
      – PersonEntity:
          Name:
            NameFull: Inoue T
      – PersonEntity:
          Name:
            NameFull: Rodríguez-Cid J
      – PersonEntity:
          Name:
            NameFull: Zhang L
      – PersonEntity:
          Name:
            NameFull: Yang CT
      – PersonEntity:
          Name:
            NameFull: de la Mora Jimenez E
      – PersonEntity:
          Name:
            NameFull: Zhou J
      – PersonEntity:
          Name:
            NameFull: Pérol M
      – PersonEntity:
          Name:
            NameFull: Lee KH
      – PersonEntity:
          Name:
            NameFull: Vicente D
      – PersonEntity:
          Name:
            NameFull: Ichihara E
      – PersonEntity:
          Name:
            NameFull: Riely GJ
      – PersonEntity:
          Name:
            NameFull: Luo Y
      – PersonEntity:
          Name:
            NameFull: Chirovsky D
      – PersonEntity:
          Name:
            NameFull: Pietanza MC
      – PersonEntity:
          Name:
            NameFull: Bhagwati N
      – PersonEntity:
          Name:
            NameFull: Lu S
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: 2024 Dec
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1527-7755
          Numbering:
            – Type: volume
              Value: 42
            – Type: issue
              Value: 34
          Titles:
            – TitleFull: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
              Type: main
ResultId 1